#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4220	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2258	422.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1667	1667	T	543	T,C,G	397,4,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4220	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2258	422.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1401	1401	C	663	C	528	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6922	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4073	385.7	0	.	n	.	0	T695C	SNP	695	695	T	1287	1287	C	681	C,G	499,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6922	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4073	385.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1929	1929	A	522	A,G	397,6	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6922	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4073	385.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2230	2230	G	417	G,A	330,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6922	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4073	385.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2563	2563	C	506	C,A	371,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6922	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4073	385.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2637	2637	A	500	A,T	370,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6922	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4073	385.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3189	3189	C	463	C,G,A	365,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6922	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4073	385.7	0	HET	.	.	.	C2525T,G	.	2525	2525	C	3117	3117	C	451	C,T,G	276,83,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	322	folP	855	855	100.0	folP.l6.c4.ctg.1	1949	37.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1166	1168	AGC	53;51;51	A;G;C	43;43;43	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	580	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3711	34.9	1	SNP	p	S91F	1	.	.	271	273	TTC	729	731	TTC	59;59;59	T;T;C	46;45;46	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	580	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3711	34.9	1	SNP	p	D95G	1	.	.	283	285	GGC	741	743	GGC	60;60;62	G;G;C	47;46;43	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	580	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3711	34.9	1	SNP	p	G95N	0	.	.	283	285	GGC	741	743	GGC	60;60;62	G;G;C	47;46;43	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	176	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1503	26.2	1	SNP	p	G45D	0	.	.	133	135	GGC	539	541	GGC	41;43;43	G;G;C	30;30;32	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	84	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1095	16.6	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	35	A	26	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3228	37.5	1	SNP	p	D86N	0	.	.	256	258	GAC	592	594	GAC	47;47;49	G;A;C	38;34;36	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3228	37.5	1	SNP	p	R87W	0	.	.	259	261	CGT	595	597	CGT	49;49;49	C;G;T	39;38;39	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3228	37.5	1	SNP	p	R87I	0	.	.	259	261	CGT	595	597	CGT	49;49;49	C;G;T	39;38;39	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3228	37.5	1	SNP	p	S87R	1	.	.	259	261	CGT	595	597	CGT	49;49;49	C;G;T	39;38;39	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3228	37.5	1	SNP	p	S88P	0	.	.	262	264	TCC	598	600	TCC	50;50;50	T;C;C	40;38;40	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	612	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3089	44.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1775	1777	GGC	40;41;41	G;G;C	33;32;33	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1286	1288	GCA	74;75;76	G;C;A	58;57;59	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1289	1291	ATC	76;76;78	A;T;C	60;60;62	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1301	1303	GTG	83;83;83	G,A;T,A;G	64,1;64,1;65	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1301	1303	GTG	83;83;83	G,A;T,A;G	64,1;64,1;65	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1805	1807	ACC	77;77;68	A;C,A;C	52;51,1;49	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1859	1861	GCG	59;60;60	G;C,G;G	46;44,1;45	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1859	1861	GCG	59;60;60	G;C,G;G	46;44,1;45	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1982	1984	AGC	48;48;51	A,C;G;C	42,1;43;47	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1991	1993	GGC	47;46;46	G;G;C	43;41;40	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	560	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2503	48.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2009	2011	CCG	39;34;33	C,G;C;G	32,1;28;27	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	930	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3235	62.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1760	1762	CCG	49;49;49	C;C;G	42;43;42	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	184	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1500	26.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	344	344	C	10	C	7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	38	porB1a	984	112	91.96	porB1a.l6.c30.ctg.1	588	7.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	503	505	ACG	14;14;14	A;C;G	10;10;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	38	porB1a	984	112	91.96	porB1a.l6.c30.ctg.1	588	7.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	545	547	CAA	10;10;9	C;A;A	8;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	38	porB1a	984	112	91.96	porB1a.l6.c30.ctg.1	588	7.6	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	551	553	TAC	8;8;7	T;A;C	6;6;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	563	565	GAA	48;48;48	G;A;A	35;35;35	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	812	814	AAC	56;56;55	A;A;C	42;42;41	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	851	853	GAT	52;52;52	G;A;T	41;40;41	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	974	976	TCA	48;48;48	T;C;A	42;42;42	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1103	1105	ATC	59;59;59	A;T;C,A	46;45;44,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1223	1225	CAT	71;67;67	C;A;T	43;42;42	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1334	1336	GGT	68;68;68	G;G;T	47;47;47	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1433	1435	GCA	64;64;64	G;C;A	44;44;44	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	326	porB1b	1047	1047	98.95	porB1b.l6.c17.ctg.1	1920	36.2	1	SNP	p	G120K	1	.	.	358	360	AAG	809	811	AAG	57;56;56	A;A;G	43;42;42	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	14	porB3	990	116	92.24	porB3.l15.c4.ctg.1	588	4.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	503	505	ACG	8;8;8	A;C;G	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	14	porB3	990	116	92.24	porB3.l15.c4.ctg.1	588	4.8	0	.	p	.	0	T29A	NONSYN	85	87	ACC	536	538	GCC	7;7;7	G;C;C	5;5;5	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	14	porB3	990	116	92.24	porB3.l15.c4.ctg.1	588	4.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	545	547	CAA	7;7;6	C;A;A	5;5;4	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	14	porB3	990	116	92.24	porB3.l15.c4.ctg.1	588	4.8	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	551	553	TAC	5;5;4	T;A;C	3;3;3	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1714	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5300	72.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	170	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1318	30.2	1	SNP	p	V57M	1	.	.	169	171	ATG	746	748	ATG	68;68;68	A;T;G	49;49;49	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
